Table 4.
Linear regression analysis in crude and adjusted models investigating the association between hematological indices and generalized anxiety disorder according to sex.
| Variables | Generalized anxiety disorder | |||||||
|---|---|---|---|---|---|---|---|---|
| Crude model | P-value | Adjusted model 1 | P-value | Adjusted model 2 | P-value | |||
| WBC | Males | 0.17(−0.21, 0.55) | 0.38 | 0.135(−0.251, 0.522) | 0.492 | 0.11(−0.276, 0.496) | 0.577 | |
| Females | −0.21(−0.51, 0.08) | 0.16 | −0.203(−0.493, 0.087) | 0.17 | −0.20(−0.49, 0.09) | 0.18 | ||
| RBC | Males | −0.03(−0.13, 0.08) | 0.60 | −0.004(−0.107, 0.1) | 0.212 | 0.01(−0.09, 0.14) | 0.844 | |
| Females | 0.03(−0.04. 0.10) | 0.42 | 0.04(−0.26, 0.112) | 0.211 | 0.041(−0.028, 0.114) | 0.24 | ||
| HGB | Males | −0.04(−0.22, 0.31) | 0.74 | 0.116(−0.247, 0.279) | 0.906 | 0.03(−0.24, 0.303) | 0.751 | |
| Females | 0.10(− 0.08, 0.28) | 0.26 | 0.148(− 0.31, 0.327) | 0.104 | 0.15(− 0.03, 0.32) | 0.11 | ||
| HCT | Males | −0.04(−0.74, 0.65) | 0.90 | 0.117(−0.583, 0.816) | 0.744 | 0.25(−0.473, 0.903) | 0.547 | |
| Females | 0.38(−0.87, 0.10) | 0.118 | 0.504(0.24, 0.985) | 0.04 | 0.494(0.114, 0.974) | 0.044 | ||
| MCV | Males | 0.32(−0.87, 1.50) | 0.60 | 0.269(−0.929, 1.466) | 0.66 | 0.231(−0.97, 1.42) | 0.706 | |
| Females | 0.32(−0.67, 1.31) | 0.52 | 0.33(−0.66, 1.32) | 0.513 | 0.34(−0.651, 1.33) | 0.501 | ||
| MCH | Males | 0.06(−0.43, 0.05) | 0.82 | 0.031(−0.468, 0.53) | 0.902 | −0.033(−0.51, 0.49) | 0.902 | |
| Females | 0.07(−0.33, 0.46) | 0.75 | 0.078(−0.321, 0497) | 0.691 | −0.08(−0.32, 0.48) | 0.69 | ||
| MCHC | Males | −0.05(−0.24, 0.15) | 0.63 | −0.33(−0.229, 0.162) | 0.737 | −0.047(−0.25, 0.15) | 0.664 | |
| Females | −0.05(–0.19, 0.09) | 0.47 | 00.039(−0.197, 1.099) | 0.584 | −0.038(−0.018, 0.099) | 0.584 | ||
| RDW | Males | 0.001(−0.12, 0.12) | 0.98 | −0.015(−0.133, 0.106) | 0.807 | −0.01(−0.13, 0.106) | 0.854 | |
| Females | −0.13(−0.26, 0.003) | 0.06 | −0.143(−0.274, −0.012) | 0.032 | −0.15(−0.277, −0.015) | 0.029 | ||
| PLT | Males | 4.83(−5.77, 15.43) | 0.37 | 6.794(−3.742, 17.452) | 0.211 | 6.86(−3.86, 17.58) | 0.198 | |
| Females | 1.03(−7.75, 9.82) | 0.82 | 2.267(−0.493, 11.027) | 0.612 | 2.29(−6.492, 11.072) | 0.609 | ||
| N/L(NLR) | Males | 0.22( 0.09, 0.34) | 0.001 | 0.208(0.282, 0.334) | 0.001 | 0.22(0.09, 0.34) | 0.001 | |
| Females | −0.06(−0.15, 0.04) | 0.23 | −0.81(−0.184, 0.012) | 0.086 | −0.08(−0.17, 0.01) | 0.1 | ||
| N | Males | 2.79( 0.07, 5.51) | 0.04 | 2.35(−0.451, 5.102) | 0.094 | 2.69(−0.08, 5.46) | 0.06 | |
| Females | −0.82(−2.82, 1.19) | 0.42 | −1.313(−3.431, 0.575) | 0.164 | −1.34(−3.36, 0.652) | 0.187 | ||
| L | Males | −2.79( −5.33, −0.26) | 0.03 | −2.454(−5.22, 0.114) | 0.061 | −2.71(−5.39, −0.136) | 0.039 | |
| Females | 0.81(−1.06, 2.68) | 0.40 | 1.357(−0.498, 3.212) | 0.152 | 1.292(−0.54, 3.18) | 0.173 | ||
| M | Males | −0.03(−0.41, 0.36) | 0.89 | 0.062(−0.327, 0.451) | 0.753 | 0.067(−0.324, 0.45) | 0.737 | |
| Females | 0.07(−0.20, 0.33) | 0.62 | 0.122(−0.137, 0.381) | 0.357 | 0.15(−0.14, 0.38) | 0.386 | ||
| MPV | Males | −0.01(−0.14, 0.12) | 0.88 | −0.024(−0.184, 0.11) | 0.726 | −0.02(−0.15, 0.0111) | 0.726 | |
| Females | 0.1 ( 0.006, 0.20) | 0.045 | 0.101(0.002, 0.095) | 0.045 | 0.102(0.003, 0.201) | 0.045 | ||
| PCT | Males | 0.004(−0.004, 0.01) | 0.39 | 0.005(−0.003, 0.013) | 0.246 | 0.005(−0.003, 0.013) | 0.23 | |
| Females | 0.004(−0.003, 0.01) | 0.27 | 0.005(−0.002, 0.011) | 0.171 | 0.005(−0.002, 0.011) | 0.16 | ||
| PDW | Males | −0.03(−0.003, 0.05) | 0.38 | −0.197(−0.276, 0.006) | 0.212 | −0.103(−0.27, 0.07) | 0.234 | |
| Females | −0.06(−0.18, 0.07) | 0.37 | −0.065(−0.187, 0.057) | 0.296 | −0.06 (−0.18, 0.058) | 0.303 | ||
The Crud model was not adjusted.
Model 1 included age, education, physical activity, body mass index (BMI). histories of arteritis rheumatoid, diabetes and hypertension. Adjusted model 2 included all variables in model 1 and additionally included smoking, alcohol consumption, opium use. Significant values are in bold.